Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuticals
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) today announced that it has withdrawn its offer to acquire ISTA Pharmaceuticals Inc. (Nasdaq: ISTA) for $7.50 per share in cash. Valeant had previously announced that the offer would only remain open until January 31, 2012, but withdrew the offer today due to lack of progress.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.